Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Do you want to connect with others who bought MAPs programs and get personalized help
Answer: GLP-3 retatrutide (LY3437943) is an investigational triple-agonist drug from Eli Lilly targeting GLP-1, GIP, and glucagon receptors
Starting with one from Endocrine Reviews from May 2024 by Hoong-Wei Gan, Manuela Cerbone, and Mehul Tulsidas Dattani, Appetite- and Weight-Regulating Neuroendocrine Circuitry in Hypothalamic Obesity , says Abel, provided a comprehensive overview of the complex interacting pathways by which the hypothalamus receives numerous peripheral hormonal signals from the gut and adipose tissue, such as leptin, ghrelin, glucagon-like peptide 1 (GLP1), and others and integrate these to regulate feeding behavior, energy expenditure, and body weight
Compared to the OGTT, only a limited number of studies have reported on the mixed meal test 53,89
